BioCentury
ARTICLE | Company News

Dov, Euthymics deal

July 26, 2010 7:00 AM UTC

Euthymics completed its previously announced reverse merger with Dov for up to $2 million in cash, or about $0.015 per share. The combined company, which will remain private, retains Euthymics' name a...